A new Lancet study describes the first locally-transmitted case of SARS-CoV-2, which causes COVID-19, in the USA from a woman who recently traveled to China and transmitted the infection to her husband.
People who rate themselves as highly knowledgeable about new viral infection threats could also be more likely to believe they don't know enough.
Researchers report the median time from exposure to symptoms for the COVID-19 virus is 5.1 days. 97.5% of people who develop symptoms of coronavirus will do so within 11.5 days of exposure. For every 10,000 people quarantined for 14 days, an estimated 101 would develop symptoms after release.
A clinically proven drug known to block an enzyme essential for the viral entry of Coronavirus into the lungs blocks the COVID 19 (SARS-CoV-2) infection. The drug, Camostat mesilate, is a drug approved in Japan to treat pancreatic inflammation. Results suggest this drug may also protect against COVID 19. Researchers call for further clinical trials.
Quarantine as a means to protect the public from health threats, such as the current Coronavirus outbreak, may have a lasting psychological impact on people. Being quarantined raises the risk for PTSD and other mental health disorders. However, it remains the safest option for those exposed to infection to prevent disease spread.
Researchers explain how the general public can help protect themselves and those around them from coronavirus.
Infectious disease experts report between 40% and 70% of adults could become infected with coronavirus during the outbreak. In a new interview, Dr. Lipsitch, head of Harvard's T.H. Chan School of Public Health's Center for Communicable Disease Dynamics, discusses the risks and spread potential of COVID-19, and addresses how the infection could impact children's' health.
